Defunct Company
Total Trials
1
As Lead Sponsor
As Collaborator
0
Total Enrollment
24
NCT02243787
Safety and Tolerability Study of COVA322 in Patients With Stable Chronic Moderate-to-severe Plaque Psoriasis
Phase: Phase 1/2
Role: Lead Sponsor
Start: Apr 30, 2014
Completion: Not specified